ABI is our 12-week course and training program in biomedical entrepreneurship. ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University
For further information, contact:
Connor Dowling
Associate, BioVenture eLab
BioPharma Alliances and Research Collaborations
Weill Cornell Medicine
T 646-962-6186
cod2006@med.cornell.edu
@CDNYCY4 (Twitter)